The Goldman Sachs Group Has Lowered Expectations for GE HealthCare Technologies (NASDAQ:GEHC) Stock Price

GE HealthCare Technologies (NASDAQ:GEHC) had its target price decreased by analysts at The Goldman Sachs Group from $97.00 to $81.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective would suggest a potential upside of 11.20% from the stock’s previous close.

GEHC has been the subject of a number of other reports. Piper Sandler raised their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Jefferies Financial Group raised their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. BTIG Research restated a “buy” rating and issued a $91.00 price target on shares of GE HealthCare Technologies in a report on Thursday, March 19th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average target price of $90.75.

GE HealthCare Technologies Trading Down 1.2%

GEHC traded down $0.91 during trading on Thursday, reaching $72.84. 1,607,500 shares of the stock traded hands, compared to its average volume of 3,600,214. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $33.24 billion, a PE ratio of 16.02, a P/E/G ratio of 1.55 and a beta of 1.17. The stock’s 50-day moving average is $76.37 and its 200 day moving average is $77.95. GE HealthCare Technologies has a 12 month low of $59.70 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts anticipate that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

Institutional Trading of GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of GEHC. Auto Owners Insurance Co increased its stake in GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. Norges Bank bought a new stake in GE HealthCare Technologies during the 4th quarter valued at $596,024,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in GE HealthCare Technologies during the 4th quarter valued at $533,655,000. Capital Research Global Investors increased its stake in GE HealthCare Technologies by 25.0% during the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares in the last quarter. Finally, Cynosure Group LLC increased its stake in GE HealthCare Technologies by 21,045.4% during the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock valued at $358,055,000 after purchasing an additional 4,344,817 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.